Plant Genome Editing Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/JP2017/018263, filed May 15, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,499,158 | Method for Modifying Plant In force · Medium confidence UsedRemaining | Kaneka Corporation and KWS Saat SE & Co. KGaA | In force | Medium confidence | ||
| US 11,591,605 | Plant Genome Editing Method In force · High confidence | Kaneka Corporation | In force | High confidence | ||
| US 11,518,998 | Method for Creating Transformed Plant In force · High confidence | Kaneka Corporation | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.